Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA ClinicalTrials.gov Report Will Show Growing Rate Of Study Listings

This article was originally published in The Pink Sheet Daily

Executive Summary

The forthcoming report also will show increased disclosure of company sponsors and drug names in trial descriptions. FDA has added language to IND acknowledgement letters to promote compliance with listing requirements.

You may also be interested in...



Acting Head Named For Office Of Women's Health

Theresa Toigo will serve as the acting director of FDA's Office of Women's Health, the agency announced Sept. 16

Acting Head Named For Office Of Women's Health

Theresa Toigo will serve as the acting director of FDA's Office of Women's Health, the agency announced Sept. 16

ClinicalTrials.Gov Participation Is Up From 2002 Rate Of 35%, FDA Report Says

Agency calls participation in ClinicalTrials.gov "mixed," despite recent increase in use.

Related Content

Topics

UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel